• <table id="gigg0"></table>
  • west china medical publishers
    Keyword
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Keyword "取石" 38 results
    • he Application of Retroperitoneoscopic Ureterolithotomy in Treatment of Impacted Stone of Upper Ureter (Reports of 58 Cases)

      摘要:目的:探討后腹腔鏡輸尿管切開取石術治療嵌頓性輸尿管結石的臨床價值和技術要點。 方法:2006年12月至 2009年3月,對58例嵌頓性輸尿管中上段結石采用后腹腔鏡輸尿管切開取石術,術中取石后于鏡下直接置入雙J管,間段縫合輸尿管切口。 結果:58例手術均獲成功,無中轉開放手術,結石清除率100%。術后創腔引流液量少,3~5d拔除引流管,1周出院,術后3周膀胱鏡下拔除雙J管。隨訪1~27個月,B超復查顯示腎積水明顯好轉或消失,無結石復發。 結論:后腹腔鏡輸尿管切開取石術治療嵌頓性輸尿管結石具有創傷小\療效好、術后恢復快等特點,明顯優于開放手術及其它手術,值得推廣應用。Abstract: Objective: To summarize our experience and evaluate the outcome of retroperitoneal laparoscopic ureterolithotomy of the upper ureter impacted stone. Methods: Between December 2006 and March 2009, 58 patients underwent retroperitoneal laparoscopic ureterolithotomy of the upper ureter. After removal of the stones, the double J was put in and interrupted suture was performed for upper ureter. Results: Retroperitoneoscopic ureterolithotomy was successful in all patients, there was neither ureteral stricture nor recurrent calculus, the blood loss ranged from 510 mL, without urine leakage occurred.The mean hospital stay was 7 days, after 3 weeks double J was removed by cystoscopy. With 127 months followup, the hydronephrosis relieved and no recurrence of ureter calculus founded. Conclusion:Retroperitoneoscopic ureterolithotomy is a safe and effective minimally invasive operation, and worth to generalization.

      Release date:2016-09-08 10:12 Export PDF Favorites Scan
    • Clinical Experience of Laparoscopic Choledocholithotomy and Primary Suture: a Report of 58 Cases

      ObjectiveTo explore the clinical efficacy and surgical techniques of laparoscopic choledocholithotomy and primary suture. MethodsWe retrospectively analyzed the clinical data of 58 patients who underwent laparoscopic choledocholithotomy and primary suture between January 2009 and December 2014. ResultsAll the 58 patients underwent the surgery successfully. Operation time was 45-125 minutes, averaging 75 minutes. Intraoperative blood loss was between 10 and 50 mL with an average of 20 mL. Postoperative hospital stay was 5-14 days with an average of 7 days. Four cases of biliary leakage were cured by conservative treatment. ConclusionWith operation indications strictly grasped and skillful operation techniques, laparoscopic choledocholithotomy and primary suture are safe and reliable with a good curative effect.

      Release date:2016-10-02 04:54 Export PDF Favorites Scan
    • Value of percutaneous transhepatic choledochoscopic lithotripsy in treatment of recurrent type Ⅱa hepatolithiasis

      ObjectiveTo investigate the feasibility and safety of percutaneous transhepatic choledochoscopic lithotripsy (PTCSL) in the treatment of recurrent type Ⅱa hepatolithiasis.MethodsAll of 293 patients with recurrent type Ⅱa hepatolithiasis admitted to the Second Affiliated Hospital of Chongqing Medical University from December 2010 to December 2017 were collected retrospectively, 82 of whom were treated with the PTCSL (PTCSL group), 211 of whom were treated with traditional open surgery (open group). The patients were matched according to the ratio of 1∶1 by using the method of propensity score matching, then the patients were compared after matching.ResultsA total of 59 pairs were successfully matched, that was, there were 59 patients in the PTCSL group and open group, respectively. Compared with the open group, the PTCSL group had the similar conditions such as the gender, age, preoperative Child-Pugh classification, and times of previous biliary operations, etc. (P>0.050). There was no perioperative death in both groups. There were no significant differences between the two groups in the success rate, operation time, times of operations, time of T tube removal after operation, stone residual rate, and stone recurrence rate (P>0.050). Although the hospital costs of the PTCSL group was higher than that of the open group (P<0.050), the PTCSL group had various advantages, such as less intraoperative bleeding, smaller incisional scar, shorter hospital stay and postoperative ventilation time, and lower rate of total postoperative complications (P<0.050).ConclusionsAfter learning curve, PTCSL has many advantages over traditional open surgery in treatment of recurrent type Ⅱa hepatolithiasis. PTCSL is a minimally invasive surgery, which is safe and effective.

      Release date:2020-12-25 06:09 Export PDF Favorites Scan
    • 小切口與腹腔鏡保膽取石術治膽囊結石的效果觀察

      目的比較小切口保膽取石術與腹腔鏡保膽取石術在治療膽囊結石中的療效。 方法選取2007年8月-2012年6月收治的膽囊結石患者140例,分為研究組(n=80,采取小切口保膽取石術)及對照組(n=60,采取腹腔鏡保膽取石術),對比分析兩組的臨床療效。 結果手術時間、出血量、腸道恢復時間、住院時間、中轉開腹率、結石殘留率、結石復發率、術后并發癥、鎮痛藥使用等方面,兩組差異均無統計學意義(P>0.05)。研究組與對照組平均住院費用分別為(5 014.8±670.4)、(7 852.5±954.6)元,研究組明顯低于對照組,差異有統計學意義(t=-20.659,P<0.001)。 結論小切口保膽取石術與腹腔鏡保膽取石術都是微創、安全、療效確切的保膽取石手術方式,應根據患者的實際情況選擇合適的手術方式。小切口保膽取石術的優點在于無需價值高昂的設備、術者不需要專門培訓、適應證廣、住院費用相對較低、簡單易學,更值得在基層醫院推廣。

      Release date: Export PDF Favorites Scan
    • Effect of different tracts of percutaneous nephrolithotomy on the efficacy of complete staghorn calculus

      ObjectiveTo explore the impact of different tracts on the effectiveness and safety of percutaneous nephrolithotomy (PCNL) on complete staghorn calculus.MethodsPatients with complete staghorn calculus who underwent single channel PCNL by the same surgeon in West China Hospital of Sichuan University from October 2009 to August 2019 were included. The removing time, the rate of immediate stone removal, the average extubating time, and the incidences of postoperate complications such as fever and bleeding were analyzed statistically.ResultsA total of 379 patients were included. There were 146 cases in the upper tract group, 170 cases in the lower tract group and 63 cases in the middle tract group. Compared with the upper and middle tract groups, the lower tract group had shorter stone removing time [(50.34±18.52) vs. (53.41±22.75) vs. (41.79±17.45) min, P<0.001], shorter average extubating time [(5.53±1.83) vs. (6.17±1.44) vs. (4.96±1.91) d, P=0.007]. The rate of immediate stone removal was higher in the the upper tract group (40.56% vs. 32.79% vs. 34.71% ), but there was no statistical difference among the three groups (P=0.447). There was no significant difference among the three groups in the fever incidence (25.44% vs. 24.24% vs. 26.85%, P=0.938) or bleeding incidence (3.54% vs. 3.03% vs. 4.03%, P=1.000). In addition, there were 8 cases of pleural injury in the upper tract group.ConclusionsCompared with the lower and middle tract, PCNL with upper tract has a higher rate of removing stones for complete staghorn calculus, but there was no significant difference among the three groups. The incidences of bleeding and fever after surgery are similar in the three groups, but the risk of pleural injury may be increased in the upper tract group.

      Release date:2021-09-24 01:23 Export PDF Favorites Scan
    • Current Status of Clinical Research on Endoscopic Cholecystolithotomy with Reservation of Gallbladder

      Objective To introduce the current status of clinical research on endoscopic cholecystolithotomy with reservation of gallbladder. Methods Literatures related to the basis, advantage, indication, contraindication, operative method and current controversy were reviewed and summarized. Results The objective  evidences were afforded by postoperative complications of cholecystectomy for endoscopic cholecystolithotomy with reservation of gallbladder. The progress of endoscopic technique made it possible for reservation of gallbladder. The controversy in endoscopic cholecystolithotomy with reservation of gallbladder was focused on the choice of indications and operative procedure. Incorrect patient selection and undue pursuit of cholecystolithotomy with reservation of gallbladder would be completely opposite to the treatment of gallstone. Conclusion It is feasible for endoscopic cholecystolithotomy with reservation of gallbladder to remove completely stone and reserve gallbladder function, but further investigation and long-term follow up are required to delineate gallstone recurrence after operation.

      Release date:2016-09-08 11:05 Export PDF Favorites Scan
    • Minimally Invasive Percutaneous Nephrolithotomy Report of 41 Cases

      目的:探討微創經皮腎穿刺取石術(MPCNL)治療腎結石的療效。方法:采用MPCNL治療41例腎結石患者,其中腎石30例(結石直徑gt;2.0 cm),輸尿管上段結石11例(結石直徑1.0~2.0 cm);單側結石37例,雙側結石4例。結果:41例手術均獲成功。手術時間45~120 min,平均52.7 min,無一例改開放手術。本組腎結石病例單次結石清除26例(86.7%),4例殘余結石行二期手術取凈;輸尿管上段單次結石清除率100%。結論:MPCNL 是一種有效的治療腎結石的方法,并具有創傷小、取石率高、恢復快等優點。

      Release date:2016-09-08 09:54 Export PDF Favorites Scan
    • Clinical characteristics associated with hospital infections in patients undergoing endoscopic retrograde cholangiopancreatography and laparoscopic common bile duct exploration for common bile duct stones

      Objective To analyze the clinical characteristics associated with hospital infections in patients with common bile duct stones treated by endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic common bile duct exploration (LCBDE), thereby providing a basis for selecting treatment strategies and formulating hospital infection prevention measures for such patients. Methods Patients with common bile duct stones at Jiangsu Provincial People’s Hospital between January 2020 and July 2023 were retrospectively selected and divided into ERCP and LCBDE groups according to their surgical methods. Basic patient data, length of hospital stay, hospitalization costs, perioperative infection-related indicators, and occurance of hospital infections were compared between groups. Results A total of 402 patients were enrolled, with 242 in the ERCP group and 160 in the LCBDE group. Significant differences were noted in smoking, alcohol consumption, history of lung diseases, history of heart diseases, history of cholecystectomy/biliary surgery, presence of cholecystitis, presence of cholecystolithiasis, number of stones, maximum stone diameter, common bile duct diameter, total hospital stay, and total expenses (P<0.05). Twenty-four hours before surgery, except for the neutrophil count, which was slightly higher in the ERCP group than that in the LCBDE group (P=0.043), the infection-related indicators did not differ significantly between the two groups (P>0.05). Twenty-four hours after surgery, the levels of serum white blood cell, neutrophil, and aspartate aminotransferase in the ERCP group were lower than those in the LCBDE group (P<0.05), and the levels of alkaline phosphatase and gamma-glutamyl transferase in the ERCP group were higher than those in the LCBDE group (P<0.05). A total of 179 bile samples were collected and tested, identifying 137 strains of pathogenic bacteria (78 in the ERCP group and 59 in the LCBDE group). In the ERCP group, 42 strains (53.85%) were Gram-negative bacteria, 34 strains (45.59%) were Gram-positive bacteria, and 2 strains (2.56%) were fungi; in the LCBDE group, 33 strains (55.93%) were Gram-negative bacteria and 26 strains (44.07%) were Gram-positive bacteria. No significant difference was observed in the composition of pathogenic bacteria between the two groups (χ2=1.174, P=0.695). Among the 402 patients, 38 cases of hospital infection occurred postoperatively, with an infection rate of 9.45%. The difference in the infection rate between the ERCP group and the LCBDE group were statistically significant (11.98% vs. 5.63%; χ2=4.550, P=0.033). The main sites of infection were bloodstream, lungs, and abdominal-pelvic cavity. Conclusions The predominant pathogens isolated after both ERCP and LCBDE are Gram-negative bacteria. Compared with LCBDE, ERCP has less impact on inflammatory markers, hospital stay, and costs, but has a higher incidence of hospital infections.

      Release date:2025-07-29 05:02 Export PDF Favorites Scan
    • 經皮經肝膽道鏡碎石取石術治療膽腸吻合術后肝膽管結石病

      目的探討經皮經肝膽道鏡碎石取石術(PTCSL)必要時聯合球囊擴張治療膽腸吻合術后肝膽管結石病的可行性及安全性。方法重慶醫科大學附屬第二醫院 2015 年 12 月至 2020 年 12 月期間共有 54 例膽腸吻合術后肝膽管結石病患者接受 PTCSL 必要時聯合球囊擴張治療(符合納入標準)。回顧性收集患者的一般資料、手術情況、術后情況以及術后隨訪資料。結果54 例患者中有 52 例(96.3%)行 PTCSL 治療成功,2 例因為膽腸吻合口完全閉塞而失敗。術中出血量的中位數為 55 mL(15~520 mL);取凈結石 48 例(88.9%),結石殘留 6 例(11.1%)。術后并發癥發生率為 27.8%(15/54),無圍手術期死亡患者。取凈結石的 48 例患者獲隨訪,中位隨訪時間 33 個月(2~60 個月),有 10 例結石復發,復發率為 20.8%(10/48)。結論PTCSL 必要時聯合球囊擴張治療膽腸吻合術后肝膽管結石病具有良好的安全性和可行性,但是術后需要注意預防結石復發。

      Release date:2021-11-30 02:39 Export PDF Favorites Scan
    • 經皮腎鏡取石術后腎出血并腎功能不全一例

      Release date:2016-10-02 04:54 Export PDF Favorites Scan
    4 pages Previous 1 2 3 4 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南